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Background: Sarcomas, a heterogeneous group of tumors, are challenging to treat and require multidisciplinary
cooperation and planning. We analyzed the efficacy of flap reconstruction in patients with bone and soft tissue sarcoma.
Methods: Patient charts and operative records were retrospectively reviewed from January 2006 through October 2013
to identify sarcoma patient characteristics, postoperative complications, revisions, recurrences, and survival. Pedicled and/
or free flap reconstruction was performed in 109 patients. Flap selection was based on defect size, and exposure of
anatomically critical structures or major orthopedic implants.
Results: Of 109 patients, 71 (65.1 %) were men, and mean age was 56.4 years. Tumors most frequently located in a lower
extremity (38.7 %). Primary sarcomas comprised 79.2 % and recurrences occurred in 18.9 %. Wide resection was performed
for 65.7 %, and there were 10 planned amputations combined with flap reconstruction. A total of 111 tumors received 128
flaps: 76 pedicled flaps, 42 free flaps, and 5 combined (10 total) pedicled + free-flaps. The success rate was 94 % for the
pedicled flap group, 97 % for the free-flap group, and 100 % for the pedicle + free-flap group. Of 35 patients, 5 developed
deep prosthetic infections. Only one amputation due to disease progression was performed. Satisfactory functional
outcome was achieved in 69 %. Survival rate during a mean (standard deviation) 3(2) year follow-up was 83.5 %.
Conclusions: Primary flap reconstruction after sarcoma surgery satisfies oncologic goals. Large tumors in difficult areas can
be removed and complete tumor resection achieved. Our findings indicate a high survival rate after sarcoma surgery
utilizing flap reconstruction and a low recurrence rate.
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Soft tissue and bone sarcomas have characteristic patterns
of biologic behavior on which staging and treatment pro-
tocols are based [1]. The international incidence rate
ranges from 1.8-5 per 100,000 persons/year, with 11,410
new cases in 2013 [2]. The Finnish Cancer Registry re-
ported an incidence of 0.7 and 1.4/100.000 persons/year
for bone and soft tissue cancers [3].* Correspondence: jenny_lopez1978@hotmail.com
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sarcoma patients have drastically improved survival and
quality of life [4, 5]. Combined wide excision and adju-
vant therapy remains the standard for local control with-
out increased recurrence or mortality [6]. Nonetheless,
recent studies demonstrated that narrower margins yield
similar outcomes and complete tumor resection is the
main aim for oncology surgeons [7–9].
Significant tissue defects may result from sarcoma exci-
sions, with exposure of tendons, bones, joints, vessels, and
prosthetic material, making substantial coverage crucial.
Sarcoma patients require reconstructive procedures thatticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Patient Characteristics
Number (%)
Sex
-Women 38 (34.8 %)
-Men 71 (65.1 %)
Comorbidities
-Smoking 14 (12.8 %)
-Heart condition 27 (24.7 %)
-Diabetes 14 (12.8 %)
-Hypertension 38 (34.8 %)
Age (yr) 56.4 (20.5)
BMI (kg/m2) 26.2 (4.8)
Laboratory
-Hb (g/L) 131 (18.7)
-WBC (mm3) 7689 (2989)
-Platelets (μL) 293,981 (96997)
-Na (mEq/L) 138.9 (2.9)
-K (mEq/L) 3.95 (0.3)
-Creatinine (mg/dl) 0.42 (0.1)
-GFR (mL/min/1.73 m2) 233.4 (105)
-INR (SU) 1.12 (0.1)
BMI (body mass index), Hb (hemoglobin), WBC (white blood count), Na (sodium),
K (potassium), GFR (glomerular filtration rate), INR (international normalized ratio).
Values expressed in number (n) and percentages (%) for categorical variables; and
mean and standard deviation (SD) for continuous variables
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period, thus enabling adjuvant therapy.
Pedicled flaps are used most commonly to cover sar-
coma defects and free flaps have gained popularity and
provide fast healing, adequate functional results, and
vascularized tissue coverage [10–12].
The benefits of primary tissue reconstruction for sar-
coma patients, the most common postoperative compli-
cations, and the revision percentages remain unclear.
The aim of this retrospective study was to analyze the
results and benefits of primary tissue reconstruction in
our multidisciplinary Sarcoma Unit.
Methods
The Tampere University Hospital Sarcoma Unit registry
identified a total of 359 sarcoma patients from January
2006 through October 2013. This research was approved
by the Tampere University Hospital Research Commit-
tee and a patient photography release consent form was
obtained.
Flap reconstruction was performed in 109 of these pa-
tients. Patient charts were reviewed to determine demo-
graphic characteristics, comorbidities, pertinent laboratory
results, and body mass index (BMI). Tumor information
(location, pathology, and grade) was also collected. Surgi-
cal data included: resection type, hardware used, and de-
fect size. Flap choice included tumor/defect size (defined
through pathology specimen as length x width), tissue
type, function, and donor site availability, among others.
There were three reconstructive options: pedicled flaps,
free flaps, and pedicled + free (as two separate) flaps. Pedi-
cled flaps in our study were defined as true perforator
flaps, such as propeller flaps, and local broad-based fascio-
cutaneous or muscle flaps. Using a two-team approach,
the operating time included tumor resection, fixation, and
reconstruction. Outcome analyses of postoperative com-
plications and revisions were calculated. Early complica-
tions were defined as those occurring within the first 30
postoperative days. Postoperative pathologic margins were
studied, as well as patient functionality. Finally, disease re-
currence, progression, and patient survival were analyzed.
Data are presented as the mean (standard deviation)
unless otherwise noted. Statistical analysis was per-
formed using SPSS® version 22. For continuous variables,
p values were calculated using the Kruskal-Wallis non-
parametric test, and for the categorical variables, Fisher’s
exact test was used. Box plots were applied for defect
size analysis, and the Kaplan-Meier test was used to
analyze patient survival with Cox regression for individ-
ual variable analysis.
Results
A total of 109 sarcoma patients that underwent reconstruc-
tion were identified. Demographic information concerningcomorbidities, age, BMI, and laboratory tests is provided in
Table 1. The majority of patients (71, 65 %) were men.
Mean patient age was 56.4 years and mean BMI was
26.22 kg/m2. Age was significantly higher in the pedi-
cled group and lower in the pedicled + flap group. The
remaining demographic characteristics were not signifi-
cantly different among the study groups.
Tumor localization and presentation (primary, recur-
rent, and metastatic) are shown in Table 2. There were
more free-flap reconstructions for lower limbs and more
pedicled flap reconstructions for thoracodorsal defects.
Pedicled + free flaps were used more often for lower
trunk reconstruction (p = 0.02). Lower trunk tumors
were predominantly located in the pelvic and sacral re-
gions. Free and pedicled flaps were used equally for head
and neck, and lower trunk reconstruction. In the upper
extremities, pedicled flaps were common, due to the ver-
satility of pedicled radial forearm flaps.
The pathologic distribution of the tumors in this study
is shown in Table 3. High grade tumors comprised 60.3 %,
low grade 22.5 %, and intermediate 8.1 % (9 % not re-
ported). Neoadjuvant therapy was performed in 16 pa-
tients (14 chemotherapy and 2 radiotherapy). Adjuvant
therapy was distributed as follows: 22 patients received
only chemotherapy, 23 received only radiotherapy, and 21
received both chemotherapy and radiotherapy. According
Table 2 Tumor localization and presentation
Tumor Characteristics Number (%)
Localization
-Head and neck 8 (7,20 %)
-Thoracodorsal 23 (20,72 %)
-Abdominopelvic/ lumbosacral 27 (24,32 %)
-Upper extremity 10 (9,00 %)
-Lower extremity 43 (38,73 %)
Primarya 88 (79.2 %)
Recurrence 21 (18.9 %)
Metastasis 2 (1.8 %)
a2 patients had new primary tumors from distant sites
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formed as follows: wide (66 %), marginal (22 %), radical
(8 %), and intralesional (3.6 %) [5]. In our series, planned
pathologic wide margins were achieved in 94 % and
planned marginal resections were accomplished in 96 %.
This was possible despite the fact that 69 % of the tumors
were T2 (>5 cm). Our multidisciplinary sarcoma team fol-
lows the Scandinavian Sarcoma Group Guidelines (SSG),
which originally defined ‘the wide cuff of healthy tissue’ as
5 cm [8]. There has been a gradual shift towards accepting
narrower margins that led the SSG to redefine wide mar-
gins as a ‘cuff of 10 mm non-fascial tissue surrounding the
tumor’. This opinion has gradually changed to accept even
finer margins [8, 9]. In our series, R0 resections were ob-
tained in 85 % of cases. Under the SSG policy, adjuvant
radiotherapy is indicated if the margins are narrow and
for all high-grade soft tissue sarcomas (STS) greater than
8 cm in size [9]. Additional surgery is not recommended
unless there is a local recurrence after adjuvant radiother-
apy. Adjuvant chemotherapy is given based on tumorTable 3 Sarcoma pathology
Sarcoma Pathology Number (%)
Rabdomyosarcoma 2 (1.8 %)
Ewing 3 (2.7 %)
MPNST 3 (2.7 %)
Synovial sarcoma 6 (5.4 %)
Hemagio-angiosarcoma 7 (6.3 %)
Dermatofibrosarcoma/fibrosarcoma 9 (8.1 %)
Osteosarcoma 12 (10.8 %)
Leiomyosarcoma 12 (10.8 %)
Liposarcoma 17 (15.3 %)
Chondrosarcoma 19 (17.1 %)
Undifferentiated Pleomorphic 21 (18.9 %)
TOTAL 111 (100 %)
aValues are expressed as number and percentage. MNSPT (malignant peripheral
nerve sheath tumor)grade, histology, age, and tumor size, and not based on
the margins [13].
Reconstruction with metal implants was used for 29 %
of the patients (endoprostheses, plates, and screws or
spinal instruments) and surgical meshes for 18 % of the
patients. Endoprosthetics were used in 14 patients. Au-
tologous non-vascularized bone was used at the begin-
ning of the study in three patients, but was replaced
with vascularized bone due its clear benefits. The risk
for infection was significant in patients who underwent
endoprosthetic placement and bone grafting. In our
study, muscular flaps were the preferred choice for pros-
thetic material coverage as they serve as an ideal vascu-
lar tissue barrier. In our experience, coverage with highly
vascular tissue such as muscle is a safe method of pro-
tecting against infection and fistula formation. Addition-
ally, muscular tissue provides volume to fill the dead
space [14–17].
From a total of 111 defects, the distribution of the
soft-tissue defect size varied from 4 cm [2] to 600 cm2
(Fig. 1). Larger defects required combined reconstruc-
tions (p = 0.004).
Of 128 flaps, 42 were free, 76 pedicled, and 5 com-
bined pedicled + free (10 total). The flaps comprised
39 % musculocutaneous, 36.5 % muscular, 18.6 % fascio-
cutaneous, and 5.6 % osteofasciocutaneous. The latissi-
mus dorsi (LD) flap was most commonly performed in
the free-flap group (62 %), 4 of which were neurovascu-
lar and 2 as a chimeric flap with scapular bone. An
endoscopic LD harvest was performed in one case. An
innervated (functional) free gracilis flap was also used
for a brachial defect after a failed pedicled flap (Table 4).
The global mean operating time was 5.6(2.4) hr;
4.7(2.4) hr for the pedicled flap group (range 1–10.5),
6.6(1.8) hr for the free-flap group (2.5-11), and 7.7(0.8)
hr for the pedicled + free flap group. Surgical time was
greater in patients requiring two flaps (p = 0.001). Opera-
tive time was significantly lower for pedicled reconstruc-
tions (p = <0.0001 compared with free-flap reconstruction).
In 11 patients, delayed reconstruction was performed due
to patient condition and/or prolonged tumor resection.
The most frequent early complications encountered
were: minor necrosis (30 %), delayed wound healing (17 %),
infection (15 %), hematoma (10 %), seroma (8 %), and total
flap loss (4 %). The incidence of pedicled and free-flap
complications was not significantly different. The influence
of comorbidities on early complications was not significant,
except in total flap loss where cardiac disease appeared to
have a significant role (p = 0.012). From a total of 35 pa-
tients who underwent prosthetic material placement, 5 suf-
fered deep infections, and 3 required implant removal. One
mesh required removal as a result of deep infection.
Wound healing complications were observed following
neoadjuvant chemo- or radiotherapy. Of 14 patients
Fig. 1 Sarcoma Defect Size Distribution. Box plot showing the distribution of flap size among the reconstructive groups. Double flap reconstructions
were required for larger defect sizes (p = 0.004)
Table 4 Flap characteristics: flap type
Flap Pedicled Free
Latissimus dorsi 22 (27.1 %) 29 (61.7 %)
ALT 2 (2.4 %) 4 (8.5 %)
ALT + vastus lateralis 2 (2.4 %) 4 (8.5 %)
Vastus lateralis 5 (6.1 %) 1 (2.1 %)
Radial forearm 3 (3.7 %) 2 (4.2 %)
Fibula 1 (1.2 %) 3 (6.3 %)
Rectus abdominis TRAM/VRAM 3 (3.7 %) 1 (2.1 %)
Gracilis neurovascular - 1 (2.1 %)
Filet Flap - 2 (4.2 %)
Gluteus 9 (11.1 %) -
Gastrocnemius 14 (17.2 %) -
Local fasciocutaneous 11 (13.5 %) -
Trapezius 1 (1.2 %) -
Crista iliaca 1 (1.2 %) -
Tensor fascia lata 2 (2.4 %) -
Sartorius 1 (1.2 %) -
Soleus 1 (1.2 %) -
Biceps femoris 1 (1.2 %) -
Pectoralis 2 (2.4 %) -
TOTAL 81 (100 %) 47 (100 %)
aValues are expressed as number and percentage. ALT (anterolateral thigh),
TRAM/VRAM (transverse/vertical rectus abdominis myocutaneous)
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complications such as infections and necrosis that delayed
wound healing and required revision surgery (p = 0.10).
Both patients receiving preoperative radiotherapy presented
with complications of recurrent hematoma/seroma forma-
tion and infection that required revision surgery (p = 0.05).
The revision rates were as follows: 17 % for the pedi-
cled, 13 % for the free, and 4 % for the pedicled + free-
flap group. Wound revision for lavage and closure was
significantly greater for the pedicled + free-flap group
(p = 0.033). In the free-flap group, four patients required
revisions due to vascular compromise (two required vein
and two arterial and venous re-anastomosis); three with
reported flap survival. The overall revision differences be-
tween the study groups and the number of revisions per
patient were not significant (p = 0.086 and 0.116).
There was one total flap loss in the free-flap group
(97 % survival); 4 total flap losses for the pedicled flap
group (94 % survival), and no flap loss in the pedicled +
free flap group. The pedicled + free-flap group had sig-
nificantly more hematomas and wound healing problems
than the other groups. The reason for this was the larger
defect size in patients receiving both a pedicled and a
free-flap reconstruction. When total flap loss was en-
countered, reconstruction was performed with new free
flaps in two cases, with pedicled flaps in two cases, and
with negative wound pressure therapy and multiple revi-
sion surgery followed by skin grafting in one case. The
latter patient required fat grafting for volume replace-
ment. Systemic complications were distributed equally
among the groups and included pulmonary, cardiac,
thromboembolic events, sepsis, and renal failure.
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83.5 % (mean [standard deviation] follow-up time 3(2)
years, range 0.1-7.7 years). Analysis of the correlation
between surgical resection and recurrence revealed
that 16/73 (22 %) of the patients with wide resections,
3/24 (18 %) with marginal resections, 2/4 (50 %) with
intralesional resections, and 1/10 (10 %) with radical
resections had a recurrence. The recurrence rate did
not differ significantly among the study groups. Using
the American Joint Committee on Cancer TNM
clinical-pathologic staging for sarcomas, 28 % were
stage I (9 % IA, 19 % IB), 29 % were stage II (15 % IIA,
14 % IIB), and 21 % stage III, for tumors that could be
staged; [1] 24 patients (22 %) were considered stage IV.
The common sites for tumor metastasis were lung
(70 %), bone (15 %), liver (7 %), groin (7 %), and pelvis
(4 %). One of the patients had disease progression that
led to extremity amputation. Two early deaths were
reported (within the first month of surgery). Survival
ratios are provided in Fig. 2, and no significant differ-
ences were detected in the reconstruction groups. Sar-
coma tumor recurrences significantly affected survival,
with an 89 % risk of death.
The value of plastic surgery reconstruction was dem-
onstrated in our series. Twelve patients would have been
considered inoperable if flap reconstruction was notFig. 2 The Kaplan-Meier survival curve. Survival did not differ significantly aavailable. Similarly, without flap reconstruction, 19 pa-
tients would have been considered candidates for ampu-
tation. Distal limb tumors, tumors resected after whoops
procedures, and axial tumors that required flap coverage
due to defect size and vital organ exposure benefited the
most from reconstructive surgery.
In our series, 96 % of the lower limb and trunk patients
were able to ambulate after sarcoma resection and recon-
struction, 41 % of these with assisted ambulation or with
minor gait disorder. Considering that 27 % of the tumors
involved the spine, sacrum, or pelvis axis, and that 39 %
involved a lower extremity, functionality was considered
adequate Figures 3 and 4 include examples fo hard and
soft tissue sarcomas treated in our Department.
Discussion
The goal of primary tissue reconstruction after sarcoma
resection is to reconstruct the excised tissue and secure
wound healing by filling the dead space. The possibility of
primary tissue reconstruction allows the orthopedic on-
cologist to proceed freely with complete tumor ablation
without worrying about wound closure. The SSG guide-
lines have gradually shifted to accept narrower margins.
The patients studied here, however, were operated on
at a time when the aim was to achieve wide margin of
at least 10 mm of nonfascial tissue. This aim led tomong the three reconstructive groups during the study period
Fig. 3 Patient Photographs. 31 year-old male with left ilium chondrosarcoma, and resection of the medial ilium, partial sacrum, and LV (5th lumbar
vertebra) hemicorporectomy, fixation and reconstruction with an osteomyocutaneous latissimus dorsi free-flap and saphenous vein transposition.
a,b Preoperative images. c,d Biopsy specimen and defect. e Venous transposition. f,g Postoperative images. h,i Patient flap progression
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margins remain the standard resection for sarcomas, nar-
rower margins have demonstrated comparable outcomes
based on longer follow-up and survival numbers [18, 19].
Marginal resections provide similar survival rates com-
pared with wide resections [8, 9, 13, 18, 19]. Intralesionalresection yields the highest numbers of recurrence at
surgical margins [20]. In our study, the greatest percent-
age of recurrence was detected in patients undergoing
intralesional resections, followed by wide, marginal, and
radical, but the differences were not statistically signifi-
cant. We attribute this result to the remarkably low
Fig. 4 a,b,c. Patient Photographs. Example of the value of plastic
surgery. Patient with megaprosthesis of the knee after sarcoma
resection and the resulting defect. Reconstruction with ALT free
flap and results
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with the wide or marginal resections.
Although neoadjuvant chemo- and radiotherapy nega-
tively affect wound healing, the effects were not significant.
The very low number of patients receiving neoadjuvant
therapy may have influenced this result. STS, the most
common type of sarcoma, is resistant to chemotherapyand therefore not commonly used in these patients. Pa-
tients with STS are usually older than those with bone sar-
coma and chemotherapeutic agents for sarcoma treatment
are highly toxic. Therefore, the benefits of chemotherapy
are lower than the possible toxic complication rates in this
group.
Adequate wound healing is mandatory for postopera-
tive adjuvant therapy [20–22]. In the past, large tumor
resections and reconstructions were avoided due to the
detrimental effects of adjuvant therapy, patient morbid-
ity, and high recurrence rate. Nonetheless, tissue transfer
from unirradiated sites can overcome the detrimental ef-
fects of adjuvant therapy on wound healing [20–22]. Sar-
coma reconstruction is associated with a high proportion
of postoperative complications, likely due to the prolonged
surgical time as well as extended postoperative bed rest
and immunosuppressive therapies. In the present study,
we found that creating two flaps significantly prolonged
the operating time. The operating time was significantly
shorter for pedicled flaps, compared with free flaps. The
main reason for this result, however, is that free-flap surgi-
cal time included local options, such as transposition flaps.
Cordeiro described major (12 %) and minor complications
(7 %) following free-flap reconstruction, reporting flap
success in 96 % of cases [12]. In our study, the number of
early complications was 17 %, but only 20 % of the pa-
tients required revision surgery. Pedicled flaps are com-
monly considered more reliable and successful for
oncologic cases, but we found that the free-flap success
rate was equivalent. Our current preference for the use of
free flaps in certain cases is due to the advantage of free-
dom of flap positioning, incorporating healthy vascular-
ized tissue, avoiding kinking or stretching of the vascular
pedicle, and quick healing periods. Adding volume and a
protective barrier to oncologic defects using reconstruct-
ive flaps provides greater tolerance for subsequent adju-
vant therapy [23–28].
Recurrences are considered high after flap reconstruc-
tion in the setting of advanced and high-grade sarcomas
[24]. Initial presentation with recurrent disease and tumor
size are important risk factors for subsequent recurrence
[20–22, 24, 29, 30]. In our series, planned margins were
achieved in over 94 % of the cases, even for large tumors.
Overall patient survival was 83.5 % for the study period,
which is higher than that reported previously, ranging
from 50 % to 80 % [1–3, 31–34]. Sarcoma recurrence is
reported to be ~25 % to 60 % [1, 2, 31–34]. In our study,
recurrence was 19 %, slightly lower than that in previous
reports. Flap reconstruction allows for complete tumor ex-
cision, and thus results in a good survival rate.
Proper flap selection is crucial in sarcoma defect re-
construction [29, 30, 35]. In general, free and pedicled
flaps were equally effective for defect coverage. The limi-
tations of the current study are the retrospective nature
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lation. Additionally, the condition of each patient was
unique, including tumor type and indication, making
their reconstruction almost impossible to compare.
Conclusions
Primary flap reconstructions after sarcoma surgery are
often performed in our center for various reasons. The
possibility for soft tissue and bone reconstruction allows
the oncologic surgeon to perform a complete tumor ex-
cision with adequate margins [5]. Primary flap recon-
struction also helps to protect orthopedic megaimplants
and avoid deep infection. Additionally, an important aim
is to maintain maximum patient function without com-
promising surgical oncologic principles. Enabling a pa-
tient to walk and return to daily activities of living after
sarcoma resection vastly improves the patient’s quality of
life. The availability of plastic surgery reconstructions
enables surgery to be performed in some patients with
complex cases, and can aid in preventing amputations in
some cases.
Performing primary flap reconstruction contributes to
satisfy the primary goal of sarcoma resection. The choice
of the reconstructive method applied is profoundly indi-
vidualized. Therapeutic planning for sarcoma patients
should be accomplished by a multidisciplinary team in-
volving oncologists, radiologists, pathologists, orthopedic
oncologists, arthroplastic and spine surgeons, and recon-
structive plastic surgeons.
Competing interests
The authors declare that they have no competing interests.
Author’ contributions
JL and KH participated in the chart review, data collection, and statistical
analysis. JL, IK, and HK designed the study and drafted the manuscript. MK,
TK-P, and ML created the study plan and main study points, participated in
the study design and coordination, and helped to draft the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
We thank Mika Helminen who contributed substantially to the data analysis
and interpretation. Source of funding for authors or manuscript preparation:
none.
Author details
1Department of Plastic Surgery, Unit of Musculoskeletal Diseases, Tampere
University Hospital, Pirkanmaa Hospital District, Teiskontie 35, PO BOX 2000,
Tampere 33521, Finland. 2Department of Orthopedics and Trauma, Unit of
Musculoskeletal Diseases, Tampere University Hospital, Tampere, Finland.
Received: 4 June 2014 Accepted: 29 May 2015
References
1. American Joint Committee on Cancer. Soft tissues. In: Fleming ID, Cooper
JS, Henson DE, editors. AJCC Cancer Staging Manual. 7th ed. Philadelphia:
Lippincott-Raven; 2010. p. 149–56.
2. National Cancer Institute 2013. Available at http://www.cancer.gov/cancertopics/
pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page1.
3. Finnish Cancer Registry 2011. Available at http://www.cancer.fi/syoparekisteri/
en/statistics/cancer-statistics/koko-maa/.4. Fisher C. Soft tissue sarcomas: Diagnosis, classification and prognostic
factors. Br J Plast Surg. 1996;49:27–36.
5. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging
of musculoskeletal sarcoma. Clin Orthop. 1980;153:106–20.
6. Malawer M, Sugarbaker PH. Musculoskeletal Cancer Surgery. Treatment of
Sarcomas and Allied Diseases. Netherlands: Springer; 2005. p. 3.
7. Angervall L, Lindblom LG. Principles of pathologic anatomic diagnosis and
classification of soft tissue sarcomas. Clin Orthop. 1993;289:9–18.
8. Trovik CS, Bauer HC, Alvegard TA. Surgical margins, local recurrence and
metastasis in soft tissue sarcomas: 559 surgically treated patients from the
Scandinavian sarcoma group register. Eur J Cancer. 2000;36:710–6.
9. Clement S. Trovik, Sigmund Skjeldal, Henrik Bauer, Anders Rydholm, and
Nina Jebsen. Reliability of Margin Assessment after Surgery for Extremity
Soft Tissue Sarcoma: The SSG Experience, Sarcoma, vol. 2012, Article ID
290698, 5 pages. doi:10.1155/2012/290698.
10. Zook EG, Russell RC, Asaadi M. A comparative study of free and pedicle
flaps for lower extremity wounds. Ann Plast Surg. 1977;59:492–9.
11. Serafin D, Geordiage NG, Smith DH. Comparison of free flaps with pedicle
flaps for lower extremity wounds. Plast Reconstr Surg. 1998;102:711–21.
12. Cordeiro PG, Neves RI, Hidalgo DA. The role of free tissue transfer
following oncologic resection in the lower extremity. Ann Plast Surg.
1994;33:9–16.
13. O’Donnell PW, Griffin AM, Eward WC, Sternheim A, Catton CN, Chung PW,
et al. The effect of the setting of a positive surgical margin in soft tissue
sarcoma. Cancer. 2014;120:2866–75.
14. Sukru Y, Chih-Hung L, Yu-Te L, Ali Engin U, Wei F-CMD. Outcome Comparison
between Free Muscle and Free Fasciocutaneous Flaps for Reconstruction of
Distal Third and Ankle Traumatic Open Tibial Fractures. Plast Reconstr Surg.
2006;117(7):2468–75.
15. Shibata D, Hyland W, Busse P, Kim K, Sentovich SM, Steele G, et al. Immediate
Reconstruction of the Perineal Wound With Gracilis Muscle Flaps Following
Abdominoperineal Resection and Intraoperative Radiation Therapy for
Recurrent Carcinoma of the Rectum. Ann Surg Oncol. 1999;6(1):33–7.
16. Hallock GG. Utility of Both Muscle and Fascia Flaps in Severe Lower
Extremity Trauma. J Trauma. 2000;48(5):913–7.
17. Arnold PG, Yugueros P, Hanssen A. Muscle Flaps in Osteomyelitis of the
Lower Extremity: A 20-Year Account. Plast Reconstr Surg. 1999;104(1):107–10.
18. Liu CY, Yen CC, Chen WM. Soft tissue sarcoma of extremities: the prognostic
significance of adequate surgical margins in primary operation and
reoperation after recurrence. Ann Surg Oncol. 2010;17:2102–11.
19. King DM, Hackbarth DA, Kirkpatrick A. Extremity soft tissue sarcoma resections:
how wide do you need to be? Clin Orthop Relat Res. 2012;470:692–9.
20. Sawamura C, Springfield DS, Marcus KJ, Perez-Atayde AR, Gerhardt MC.
Factors predicting local recurrence, metastasis and survival in pediatric soft
tissue sarcoma in extremities. Clin Orthop Relat Res. 2010;468:3019–27.
21. Kane JM, Gibbs JF, McGrath BE, Loree TR, Kraybill WG. Large, deep high-grade
extremity sarcomas: When is a myocutaneous flap reconstruction necessary?
Surg Oncol. 1999;8:205.
22. Chao AH, Chang DW, Shuaib SW, Hanasono MM. The Effect of Neoadjuvant
versus Adjuvant Irradiation on Microvascular Free Flap Reconstruction in
Sarcoma Patients. Plast Reconstr Surg. 2012;129:675–82.
23. Kim JY, Subramanian V, Yousef A, Rogers BA, Robb GL, Chang DW. Upper
Extremity Limb Salvage with Microvascular Reconstruction in Patients with
Advanced Sarcoma. Plas Reconstr Surg. 2004;114:400–8.
24. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of
prognostic factors in 1,041 patients with localized soft tissue sarcomas of
the extremities. J Clin Oncol. 1996;14:1679.
25. Brennan MF. The surgeon as a leader in cancer care: Lessons learned from
the study of soft tissue sarcomas. J Am Coll Surg. 1996;182:520.
26. Spark JI, Charalabidis P, Laws P, Seben R, Clayer M. Vascular reconstruction
in lower limb musculoskeletal tumours. ANZ J Surg. 2009;79:619–23.
27. Lohman RF, Nabawi AS, Reece GP, Pollock RE, Evans GR. Soft tissue sarcoma
of the upper extremity: A 5-year experience at two institutions emphasizing
the role of soft tissue flap reconstruction. Cancer. 2002;94:2256.
28. Momeni A, Kalash Z, Stark GB, Bannasch H. The use of the anterolateral
thigh flap for microsurgical reconstruction of distal extremities after
oncosurgical resection of soft-tissue sarcomas. J Plas, Reconst Aesth Surg.
2011;64:643–8.
29. Malawer MM, Kellar-Graney K. Soft Tissue Reconstruction After Limb-Sparing
Surgery for Tumors of the Upper and Lower Extremities. Oper Tech Orthop.
2005;14:276–87.
López et al. BMC Surgery  (2015) 15:71 Page 9 of 930. Winkelmann WW. Type-B-IIIa hip rotationplasty: an alternative operation for
the treatment of malignant tumors of the femur in early childhood. J Bone
Joint Surg Am. 2000;82:814–28.
31. Lehnardt M, Kuhnen C, Drücke D, Homann HH, Joneidi Jafari H, Steinau HU.
Liposarcoma of the extremities: recent developments in surgical therapy/
analysis of 167 patients. Chirurg. 2004;75(12):1182–90.
32. Lehnardt M, Hirche A, Daigeler O, Goertz A, Ring TH, Drücke D, et al.
Weichgewebssarkome der oberen Extremität. Chirurg. 2012;83(2):143.
33. Steinau HU, Daigeler A, Langer S, et al. Limb Salvage in Malignant Tumors.
Seminars in Plastic Surgery. 2010;24(1):18–33.
34. Lehnhardt M, Daigeler A, Homann HH, Schwaiberger V, Goertz O, Kuhnen C,
et al. MFH revisited: outcome after surgical treatment of undifferentiated
pleomorphic or not otherwise specified (NOS) sarcomas of the extremities – an
analysis of 140 patients. Langenbecks Arch Surg. 2009;394(2):313–20.
35. Heller L, Levin LS. Lower extremity microsurgical reconstruction. Plas
Reconstr Surg. 2001;108(4):1029–41.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
